Class I/IIb-Selective HDAC Inhibitor Exhibits Oral Bioavailability and Therapeutic Efficacy in Acute Myeloid Leukemia
- Andrew E. Shouksmith
- , Justyna M. Gawel
- , Nabanita Nawar
- , Diana Sina
- , Yasir S. Raouf
- , Shazreh Bukhari
- , Liying He
- , Alexandra E. Johns
- , Pimyupa Manaswiyoungkul
- , Olasunkanmi O. Olaoye
- , Aaron D. Cabral
- , Abootaleb Sedighi
- , Elvin D. De Araujo
- , Patrick T. Gunning
Research output: Contribution to journal › Article › peer-review
18
Link opens in a new tab
Citations
(Scopus)